Boston Scientific Aktie

27,71EUR -0,36EUR -1,26%
<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Aktionärsstruktur

Inhaber in %
Freefloat 99,70
Fidelity Management & Research Co. LLC 9,11
Capital Research & Management Co. (World Investors) 7,74
Vanguard Group, Inc. (Subfiler) 7,62
The Vanguard Group, Inc. 7,33
Wellington Management Co. LLP 4,57
State Street Corp. 4,25
Wellington Management Co. LLP 3,82
PRIMECAP Management Co. 3,21
Janus Henderson Group Plc (Subfiler) 2,82
Vanguard Total Stock Market Index Fund 2,81
BlackRock Institutional Trust Co. NA 2,44
The Bollard Group LLC 2,40
BlackRock Fund Advisors 2,23
American Funds Growth Fund Of America 2,16

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 25 000 27 000 29 000 32 000 36 000
Umsatz pro Mitarbeiter in Mio. EUR 0,30 0,31 0,31 0,31 0,30

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 3 471 3 239 3 822 4 002 4 699
Summe Anlagevermögen 11 997 12 217 12 628 15 782 24 228
Summe Aktiva 18 133 18 096 19 042 20 999 30 565

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 5 677 5 484 5 616 7 056 10 351
Summe Fremdkapital 11 813 11 363 12 030 12 273 16 688
Summe Eigenkapital 6 320 6 733 7 012 8 726 13 877
Summe Passiva 18 133 18 096 19 042 20 999 30 565

Adresse

300 Boston Scientific Way, 01752-1234 Marlborough
Telefon +1 (508) 683-4000
Internet http://www.bostonscientific.com

Management

Arthur c. Butcher
Executive Vice President, President-Asia Pacific
Charles J. Dockendorff
Independent Director
Daniel J. Brennan
Chief Financial Officer & Executive Vice President
Dave J. Roux
Independent Director
David A. Pierce
Executive Vice President & President-MedSurg
Desiree Ralls Morrison
Secretary, Senior VP & General Counsel
Donna A. James
Independent Director
Edward J. Ludwig
Lead Independent Director
Edward Mackey
Executive Vice President-Operations
Ellen M. Zane
Independent Director
Eric Francis Yves Thepaut
President-Europe & Senior Vice President
Ian T. Meredith
Global Chief Medical Officer & Executive VP
Jeffrey B. Mirviss
SVP & President-Peripheral Interventions
Jim Cassidy
Vice President & Franchise Lead-Pain Management
Jodi Eddy
Chief Information Officer & SVP
John Bradley Sorenson
Senior Vice President-Manufacturing & Supply Chain
John Edward Sununu
Independent Director
Jonathan Richard Monson
Chief Accounting Officer, Controller & VP
Joseph M. Fitzgerald
President-Cardiac Rhythm Management Division & EVP
Kenneth Stein
Senior Vice President
Kevin J. Ballinger
President-Interventional Cardiology & EVP
Mark Bickel
VP-Finance & Global Controller-Rhythm Management
Maulik K. Nanavaty
President-Neuromodulation & Senior VP
Michael F. Mahoney
Chairman, President & Chief Executive Officer
Michael P. Phalen
President-Medical Surgery & Executive VP
Mike Jones
Vice President-Sales Endoscopy
Milad Girgis
Vice President & Franchise Lead
Nelda J. Connors
Independent Director
Nicholas Spadea-Anello
VP & General Manager-Structural Heart-LAAC
Ryan Hartman
Global Group Director-Marketing & LATAM
Scott Richard Davidson
Vice President-Corporate Strategy
Stephen P. MacMillan
Independent Director
Supratim Bose
EVP, President-Asia Pacific, Middle East & Africa
Susan Vissers Lisa
Vice President-Investor Relations
Vance Ronald Brown
Chief Corporate Counsel & Vice President
Wendy Carruthers
Senior Vice President-Human Resources
Yoshiaki Fujimori
Independent Director